ClinicalTrials.gg
CompletedNCT07912788Updated Nov 3, 2026

Effect of Temporary Tattoo Application on Body Exposure and Body Satisfaction

An interventional study of Temporary Tattoo Application in Body Image, Body Satisfaction and Sexual Health, sponsored by Inonu University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Inonu University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Sep 2025, registered Oct 2026).
Updated Nov 3, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

This randomized controlled study aimed to evaluate the effect of temporary tattoo application on women's perception of body exposure during sexual activity and body satisfaction. The study included 70 married women who met the eligibility criteria and were randomly assigned to an intervention group (n=35) or a control group (n=35). Women in the intervention group received a temporary tattoo application, while no intervention was applied to the control group. Data were collected before and after the intervention using validated measures assessing body satisfaction and body exposure during sexual activity. The study was conducted at a Family Health Center in Siirt, Türkiye.

02

Conditions studied

  • Body Image
  • Body Satisfaction
  • Sexual Health
  • Sexual Activity

Browse trials for

Keywords

  • Temporary tattoo
  • Body image
  • Body satisfaction
  • Sexual activity
  • Women
  • Nursing intervention
03

In context

Sexual Behavior

224 studies on the registry are indexed under Sexual Behavior; 30 are open to participants now.

This study's enrollment of 70 is below the median of 264 across 179 interventional studies indexed under Sexual Behavior.

Browse Sexual Behavior studies →

Lead sponsor

Inonu University is the lead sponsor of 394 studies on the registry; 95 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

**Inclusion Criteria:**

  • Aged 18 years or older
  • Being sexually active, defined as having sexual intercourse at least once per week
  • Willing to receive at least one temporary tattoo application

**Exclusion Criteria:**

  • Having a diagnosed psychiatric disorder, such as body dysmorphic disorder or major depressive disorder
  • Having a permanent tattoo on the body
  • Being pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Temporary Tattoo Group

    Women assigned to this arm received the temporary tattoo intervention. Body satisfaction and perception of body exposure during sexual activity were assessed before and after the intervention.

    Other: Temporary Tattoo Application

  • No intervention
    Control Group

    Women assigned to this arm did not receive the temporary tattoo intervention during the study period. Outcome measures were assessed at the same time points as in the intervention group.

Interventions

  • OtherTemporary Tattoo Application

    Women in the intervention group received a temporary tattoo application. The intervention was used to evaluate its effect on body satisfaction and perception of body exposure during sexual activity.

06

What researchers measure

Primary outcomes

  1. Body Appreciation Scale

    Body appreciation was assessed using the Body Appreciation Scale. The scale consists of 9 items and total scores range from 9 to 45. Higher scores indicate greater body appreciation.

    Time frame: Baseline and 1 week after baseline

Secondary outcomes

  1. Body Exposure During Sexual Activity

    Body exposure during sexual activity was assessed using the Body Exposure During Sexual Activities Questionnaire (BESAQ). The scale consists of 28 items. The total score is divided by the number of items, resulting in a mean score ranging from 0 to 4. Higher scores indicate greater body-image-related self-consciousness and avoidance during sexual activity.

    Time frame: Baseline and 1 week after baseline

07

Study locations

1 site
  • Şehit Tülay Çelik Family Health Center
    Siirt, Siirt 56100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Mar 2026, 6 months.

Of 106 non-industry interventional studies with no phase under Sexual Behavior, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 47. This study's 6 months is below that.

Counting every sponsor, half of 107 studies reached it within 23 months; a quarter within 11 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 3, 2026
StartActual
Sep 1, 2025
Primary completionActual
Mar 1, 2026
CompletionActual
Mar 1, 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07912788
Lead sponsor
Inonu University
Responsible party
Muhammed Burak Bilgin (Principal Investigator, Inonu University) — Principal investigator
First posted
Nov 3, 2026
Start date
Sep 1, 2025
Primary completion
Mar 1, 2026
Completion
Mar 1, 2026
Last update
Nov 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion